| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 66.1k | $11.14 | $735.9k | | 05/31/2023 |
| 05/27/2022 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 41.6k | $17.33 | $720.9k | | 05/27/2022 |
| 11/17/2021 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 25k | $79.94 | $2M | | 11/17/2021 |
| 06/26/2021 | Sarepta Therapeutics, Inc. | SRPT | Payment of Exercise | Common Stock | 17.8k | $80.40 | $1.4M | | 06/26/2021 |
| 05/19/2021 | Relay Therapeutics, Inc. | RLAY | Grant | Stock Option (Right to Buy) | 16k | $30.09 | $481.4k | | 05/19/2021 |
| 12/31/2020 | Sarepta Therapeutics, Inc. | SRPT | Payment of Exercise | Common Stock | 37.1k | $170.49 | $6.3M | | 12/31/2020 |
| 07/20/2020 | Relay Therapeutics, Inc. | RLAY | Purchase | Common Stock | 25k | $20.00 | $500k | | 07/20/2020 |
| 12/31/2019 | Sarepta Therapeutics, Inc. | SRPT | Payment of Exercise | Common Stock | 37.2k | $129.04 | $4.8M | | 12/31/2019 |
| 08/12/2019 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 8.5k | $122.76 | $1M | | 08/12/2019 |
| 08/12/2019 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 7.8k | $123.41 | $961.6k | | 08/12/2019 |
| 10/30/2018 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 13.6k | $120.26 | $1.6M | | 10/30/2018 |
| 10/30/2018 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 3.1k | $120.94 | $379k | | 10/30/2018 |
| 08/15/2018 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 16k | $125.26 | $2M | | 08/15/2018 |
| 06/26/2018 | Sarepta Therapeutics, Inc. | SRPT | Payment of Exercise | Common Stock | 36.9k | $135.53 | $5M | | 06/26/2018 |
| 11/08/2017 | Sarepta Therapeutics, Inc. | SRPT | Purchase | Common Stock | 38.1k | $52.44 | $2M | | 11/08/2017 |
| 06/09/2017 | Endo International plc | ENDP | Grant | Ordinary Shares | 23.9k | $0.00 | $0 | | 06/09/2017 |
| 06/09/2017 | Endo International plc | ENDP | Payment of Exercise | Ordinary Shares | 11.5k | $11.49 | $132k | | 06/09/2017 |
| 05/05/2016 | Endo International plc | ENDP | Grant | Ordinary Shares | 9.4k | $26.59 | $250k | | 05/05/2016 |
| 05/05/2016 | Endo International plc | ENDP | Grant | Ordinary Shares | 9.4k | $26.59 | $250k | | 05/05/2016 |
| 05/05/2016 | Endo International plc | ENDP | Sale | Ordinary Shares | 4.5k | $26.59 | $120k | | 05/05/2016 |
| 10/20/2015 | Skye Bioscience, Inc. | NMUS | Grant | | 60k | $0.00 | $0 | | 10/20/2015 |
| 08/20/2015 | Skye Bioscience, Inc. | NMUS | Conversion | Common Stock | 312.5k | $0.00 | $0 | | 08/20/2015 |
| 08/20/2015 | Skye Bioscience, Inc. | NMUS | Conversion | Series A Preferred Stock | 100k | $0.00 | $0 | | 08/20/2015 |
| 06/01/2015 | Skye Bioscience, Inc. | NMUS | Grant | Stock Option (Right to Buy) | 40k | $3.00 | $120k | | 06/01/2015 |
| 02/21/2014 | ALLERGAN INC | AGN | Sale | Common Stock | 0.76 | $125.70 | $95.5 | | 02/21/2014 |
| 02/21/2014 | ALLERGAN INC | AGN | Grant | Employee Stock Option (Right to Buy) | 70.4k | $125.07 | $8.8M | | 02/21/2014 |
| 02/14/2014 | ALLERGAN INC | AGN | Sale | Common Stock | 84k | $124.40 | $10.4M | | 02/14/2014 |
| 02/14/2014 | ALLERGAN INC | AGN | Payment of Exercise | Common Stock | 13 | $124.57 | $1.6k | | 02/14/2014 |
| 02/14/2014 | ALLERGAN INC | AGN | Exercise | Employee Stock Option (Right to Buy) | 84k | $55.98 | $4.7M | | 02/14/2014 |
| 08/30/2012 | ALLERGAN INC | AGN | Sale | Common Stock | 100k | $85.78 | $8.6M | | 08/30/2012 |
| 08/30/2012 | ALLERGAN INC | AGN | Exercise | Employee Stock Option (Right to Buy) | 100k | $36.15 | $3.6M | | 08/30/2012 |
| 02/22/2012 | ALLERGAN INC | AGN | Payment of Exercise | Common Stock | 148 | $87.27 | $12.9k | | 02/22/2012 |
| 02/22/2010 | ALLERGAN INC | AGN | Grant | Common Stock | 314 | $0.00 | $0 | | 02/22/2010 |
| 02/22/2010 | ALLERGAN INC | AGN | Grant | Employee Stock Option (Right to Buy) | 92.6k | $59.13 | $5.5M | | 02/22/2010 |
| 02/12/2010 | ALLERGAN INC | AGN | Payment of Exercise | Common Stock | 721 | $58.97 | $42.5k | | 02/12/2010 |